Jackson Creek Investment Advisors LLC Repligen Corp Transaction History

Jackson Creek Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$194.77 - $324.21 $1.16 Million - $1.94 Million	-5,977 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$165.87 - $220.95 $204,020 - $271,768	-1,230 Reduced 17.07%	5,977 $1.19 Million
Q1 2021 May 27, 2021	SELL	$180.37 - $226.26 $36,615 - $45,930	-203 Reduced 2.74%	7,207 $1.4 Million
Q4 2020 Feb 03, 2021	BUY	$148.08 - $206.57 $187,173 - $261,104	1,264 Added 20.57%	7,410 $1.42 Million
Q3 2020 Nov 09, 2020	BUY	$122.51 - $158.27 $752,946 - $972,727	6,146 New	6,146 $907,000

479

54.9M

297K

343K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.